Retail squeeze · 50 dossiers

Reclaim leg running straight into the binary: 2026-08-03 +8% to $63.52 on Meta's WhatsApp-over-BlueBird workshop, 2026-08-04 +10.69% to $70.31 into the launch. BlueBirds 11-13 flew 2026-08-05; the 2026-08-10 Q2 call is the test — $14.7M…

Broken gov-capital quantum leg, now publicly capitulated: seven-plus down weeks, an inverse-ETF complex up to +108%, and Cramer warning it off air on 2026-07-23. Washed out but not based, heading into a binary Q2 print (est. 2026-08-05 to…

Preferred-peg repair funded by coin sales and common issuance is the live leg: MSTR closed $97.65 on 2026-08-04, a second gain after the 2026-08-03 disposal 8-K, while STRC sits at $92.53 against a $100 stated amount. The 2026-08-10 weekly…

Two unpriced agreements in six sessions — AT&T 07-27, Nasdaq Verafin 08-03 — carried QBTS back over the AT&T spike high on half the volume, but it still sits under a 50-day at $22.53. The 2026-08-06 pre-open print against a $4.03M…

Sector bid extended a second session on 2026-08-04 — QUBT $9.23, +26.4% from the 2026-07-29 close of $7.30 with no company news since 07-27 — but it was again the smallest gainer in its group and still sits under a $9.51 50-day line. The…

Quantum pure-play basket is in outright hype-cycle deflation: RGTI ~$14.19 (2026-07-17), -27% MoM, and the $14 shelf that held the May CHIPS-stake gap and the June executive-order pop has broken. Inverse quantum ETFs printing +108% and the…

The gamma-squeeze/index leg is over: PURR is -42% from its 6/1 high of $11.62 to $6.68 (7/17), through the $7.70 shelf, and now trades at roughly 0.78x the value of its 17.6M HYPE stack — a treasury premium that has flipped to a discount,…

Bitcoin-treasury premium stays inverted: the July 20 buy was just 21 BTC at $63,221 (19,921 coins), accumulation has slowed to a trickle while mNAV sits at a discount and the $2.55B ATM dilutes BTC-per-share. TD Cowen's July 22 target cut…

Late-stage small-cap CPaaS squeeze: +360% YoY into the mid-$70s, ~5% below the $79.08 high, with Citizens ($86, 2026-07-20). Riley ($85) both lifting targets in July. A confirmed Q2 print on 2026-07-29 is a binary two trading days out —…

Q1 FY27 gave the pivot real numbers (QNX $72.3M vs the $60-64M guide, FY27 raised to $594-621M), but the parabola broke: after a $13.59 high the stock fell ~37% to ~$8.54 on a meme unwind plus insider selling. Narrative maturing, price…

The May earnings-miss squeeze has fully round-tripped to a dead tape in the mid-$30s, below the ~$36 gap base, with the retail-sentiment narrative spent. The sole live driver is the 2026-08-05 fiscal-Q3 print — guided to a sharp sequential…

Court-ordered 4.5-Star legal win (2026-06-10, +18.9%) is a spent binary; the $4.23 breakout is holding near $4.32 as Canaccord lifts its target to $5.50 (2026-07-21), but the confirmed August 5 Q2 print — carrying the promised FY guidance…

Value-apparel turnaround is fundamentally accelerating — Q1 FY2026 comps +13.9%, a 21-month positive streak, a raised FY guide — but the 2026-06-02 print was the catalyst and it fired ~7-8 weeks ago. On an ~8.1M float with 10.5% short…

Deleveraging-and-refranchising turnaround with a now-dated catalyst: Q2 FY2026 prints 2026-08-06. Net leverage cut to ~5.5x from 6.7x, liquidity >$300M, but revenue still shrinks and ~23-29% of the float is short. The tradeable energy is a…

Scarcity-premium narrative is dead: DXYZ closed $22.51 on 2026-07-28, below its last reported $24.56 NAV (2026-03-31), then bounced to $25.89 on 2026-08-07 as SPCX absorbed its 911.5M-share 2026-08-06 unlock. What trades now is a near-NAV…

Street targets re-rated up to the price rather than the reverse: average PT $22.83 across 8 analysts vs the 2026-08-07 close of $20.43, after B. Riley $13→$32 (6/29) and UBS $22→$27 (7/14). The AI-power bid still works (7/30 Microsoft…

AI-native restructuring re-rate — up to 400 job cuts, FY26 EBITDA guide raised to $75–80M — plus a low-float, Russell-inclusion squeeze that popped GRPN +10% on 2026-07-16. But Q1 billings fell 1% YoY and sell-side sits at Sell: a maturing…

Post-dilution CNS microcap re-firing with the psychedelic cohort (ATAI, CMPS all moving 2026-07-16) after a June social-velocity blowoff and a 10.3M-share secondary at $4.85. Both covering shops cut targets in July while holding Buy. No…

GLP-1 reaccel gets marked to market on 2026-08-10: guide $680-700M (+25-28%) vs Q1's +4%, street at $698.9M. Since the last note the FTC/CA/UT sued (2026-07-29, N.D. Cal.), BofA cut $37 to $30, and Amazon ($50/mo Medicare GLP-1,…

The $39.49 tape is a frozen June 8 last-trade, not a live market — a ~3,600% blow-off from ~$1 on a $3M AI 'used-phone agent' deal, halted under Nasdaq T12 ever since while the board probes its own trading. Seven weeks on, still no…

June's move was a float mechanic — Russell Microcap inclusion (effective 2026-06-30) into a 40%-short float drove $8.92 to $18.13, and it is unwinding ($14.98 on 2026-07-17, -7.76%). SSS is genuinely inflecting (-6.7% → -3.8%), but price…

Genuine FY2026 turnaround (loss→$3.6M net, record $166M rev) plus a +20–22% Q1 guide drove a +36% circuit-breaker gap on 2026-06-15. Six weeks on the catalyst is spent, the only new item is a 2026-07-21 board-chair succession, and RSI-88.6…

Squeeze leg has stalled: Morgan Stanley's 2026-07-06 Underweight/$15 reinit broke the one-way upgrade cluster and knocked the stock -5.9% on 07-08. Price ~$17.18 still holds above the 50- and 200-day, but with the sell-side now two-sided…

Q1 FY27 (2026-06-11) beat in a shrinking furniture category, but the tape refused the news and no volume-confirmed reclaim has fired five weeks on. With ~27–31% short float and clustered June insider buys, the only live edge is a squeeze…

The June 30 NASA Moon BASE award ($148.3M Nova-C) bought exactly one green session before the stock broke: seven straight down days into 2026-07-13 for -24.5%, -36.5% on the month, $13.80 on 2026-07-18 versus a $38.55 May high. A live…

Cyclical staffing earnings inflection: Q2 beat (adj EPS $0.99 vs $0.95; rev $4.86B vs $4.72B) plus an above-street Q3 guide ($0.96–1.06 vs $0.88) drove a 35% short-squeeze spike to ~$52.77 on 2026-07-16. The binary catalyst has already…

De-risked Wilson-disease NDA melt-up extended rather than sold the EAN news: a 6.70M-share float ran to fresh all-time highs (~$111 on 2026-07-17) on the June-30 FDA Rare Pediatric Disease designation and clustered analyst PT hikes. The…

Sympathy bid off the Micron-led memory supercycle and Russell 2000 inclusion floored the post-parabola markdown in the low-$20s, but the ~2026-07-28 Q2 print is now the binary: Everspin must show a non-casino datacenter/AI design win or…

Re-rating leg has stalled: NUTX closed $162.98 on 2026-07-17 after five straight down days, ~20% off the $204.00 high, giving back the June breakout that B. Riley's 2026-06-26 Buy/$290 initiation topped out. A $55.0M true-up of 18,950…

Counter-UAS order cadence is accelerating — $6.9M Australian DoD (07-20) plus $70M platform-wide orders (07-22) stack on June's $40M+ — and heavy short interest keeps ONDS on squeeze screens. But the roll-up is funded by serial share…

Early-July retail squeeze is broken: OPEN lost the $4.88 insider shelf and $4.50 base, fell ~12% to $3.88 on 2026-07-24 on a technical breakdown plus fresh housing weakness, into an Aug 4 Q2 print. A rolled-over meme trading into an…

Post-Chapter-11 reorg equity: emerged 2026-06-17, ~$714M debt wiped, distressed funds (Helix, Redwood) now hold the ~22M-share float. Shares ripped +11%/month into RSI 78.5 on thin volume ahead of the first post-reorg print ~2026-07-29 — a…

Squeeze leg broke: +43% in four sessions to a $63.79 high, then management priced 3.62M shares at $55.22 (~8% discount) and closed ~$191.9M net on 2026-07-06. Price round-tripped to $37.04, under the 20- and 50-day and under the $49…

Post-dilution repair story: the June 10–15 raise (~$145M equity + $287.5M 4.75% converts, ~$11.08 conv) roughly halved the stock to ~$8 while the commercial ramp (Q1 record 8.4M-lb output, +161% revenue) held. The 2026-07-15 Mitsui/RM…

The +475% hydrogen-comeback squeeze has broken: the $3.12 Q1 gap and the 50-day both failed, price is ~$2.17 (-20% in 30d), and Susquehanna cut its target $3.75 → $2.50 on 2026-07-10. The June 30 NY Gateway close resolved as a restructure…

Post-Russell momentum squeeze in a recent-IPO e-commerce compounder has broken — down ~25% from the $29.80 high to $22 in four sessions on a macro tech rout plus a Bear Cave short report. Fundamentals intact (raised FY guide, 127% NRR) but…

The eFPGA/defense royalty squeeze has fully unwound: QUIK is ~$13, roughly 47% below the $24.33 June high, and the $18 shelf broke exactly as the Russell inclusion passed. July's post-quantum IP announcement drew no bid — good news into no…

Post-SpaceX-IPO deflation broke RDW to a 2026-07-18 low near $8.51 (~67% off the 5/28 record). A relief bounce on Huntsville/Indiana facility news and $41.5M of H1 Stalker drone orders keeps running into a ~$850M dilution ceiling: the…

Consumer-discretionary rotation lifted a heavily-shorted luxury home-furnishings name; Goldman's Neutral upgrade (PT $155, 2026-07-08) marks the squeeze going public as CEO Friedman sold 125,000 shares into the pop — a maturing rotation,…

The mania leg broke in July — the $6.33 shelf and the $4.97 range low both went — and the 2026-08-05 Q2 print handed the name a different story: revenue $15.9M (+259% YoY) vs $9.6M consensus, plus the first positive operating income and…

Dead sentiment vehicle in the give-back phase: the Russell add faded, SPCX public since 2026-06-12 gutted the SpaceX-proxy premium, and CFO turnover (Khalili effective 2026-07-27) lands right after ~$158.5M of dilution. Round-tripped from…

A record short squeeze (~32% of float) and buyout speculation, now joined by sell-side PT hikes (Alliance Global $10→$25, Jul 17), have carried SLS to a $16 test and back to ~$13; the defining Phase 3 REGAL overall-survival readout stays…

Dilution leg has broken the story: the $7B raise cleared at $27.50 on June 11 and spot is $24.18, with a live $2B ATM as forward supply. DDR contract prices +32% QoQ crush a business guiding 8.2–8.4% gross margin. Falling knife under all…

Tariff/de-minimis "secondhand wins" re-rate has matured into dead money: TDUP slid from ~$7 to $5.70, lost its ~$5.90 recovery shelf and sits on the Street-low price target while sell-side keeps trimming. The Aug 5 Q2 print is the binary…

Panagiotidis shipping shell (NOT lawnmower TTC) ran 1.93→8.50 on a sub-NAV/special-dividend story that is now fully paid out and closed. Six weeks of dead tape since the 2026-06-05 payout ($3.8M cash + 5,707,246 NEW shares); on a true…

The Novo squeeze is fully round-tripped and the funding answer arrived on 2026-07-02: a $21.8M at-the-market program via Oppenheimer/Canaccord. At $2.42 (07-15) that is ~9M shares against ~16M outstanding — the company will now sell stock…

Dormant China micro-cap attempting a fresh re-ignition on stacked headlines — a $20M non-binding term sheet for 10% of crypto-perps platform Riverbit (2026-07-14) and a Guangzhou government AI-hub agreement (2026-07-15) — but a live $6.36M…